Advertisement
Advertisement

KURA

KURA logo

Kura Oncology Inc

8.86
USD
-0.08
-0.90%
Dec 24, 12:59 UTC -5
Closed
...

Kura Oncology Inc Profile

About

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Info & Links

CEO

Troy E. Wilson

Headquarters

12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO, CA 92130, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.kuraoncology.com

Auditor

Ernst & Young LLP

Share holders

106

Employees

142

Kura Oncology Inc Statistics

Valuation Measures

Market Capitalization2

688.95M

Enterprise Value

648.95M

Enterprise Value/EBITDA(ttm)

-2.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.63

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-44.09%

Return on Invested Capital(ttm)

-43.47%

Return on Assets(ttm)

-39.57%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-229.63M

Net Income Available to Common(ttm)

-197.55M

Diluted EPS(ttm)

-2.36

Share Statistics

Beta (5Y Monthly)

0.75

52-Week Change

-13.22%

S&P 500 52-Week Change

26.50%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

77.76M

Dividend Yield

0.00%

Float4

73.49M

% Held by Insiders

5.50%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

455.30M

Total Cash Per Share(mrq)

5.85

Total Debt(mrq)

9.47M

Total Debt/Equity(mrq)

2.24%

Current Ratio(mrq)

11.47%

Quick Ratio(mrq)

11.47%

Book Value Per Share(mrq)

5.45

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.55

Free Cash Flow(ytd)

-134.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement